Jonathan Yong
Stock Analyst at UBS
(3.23)
# 998
Out of 4,786 analysts
110
Total ratings
57.89%
Success rate
9.54%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Initiates: Neutral | $5.5 | $6.68 | -17.66% | 4 | Dec 4, 2024 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.59 | +11.42% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $13.11 | +75.44% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $19.28 | +29.67% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.17 | +168.58% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $8.79 | +36.52% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.41 | +81.41% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $14.89 | +74.61% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $29.55 | -52.62% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $68.49 | +40.17% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $16.70 | +91.62% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $24.46 | +329.27% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $101.28 | -21.01% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $232.74 | -0.75% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $92.63 | +9.04% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.96 | +239.20% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $6.98 | +114.90% | 5 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $38 | $31.24 | +21.64% | 2 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $137.77 | -27.42% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $672.99 | -33.13% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.89 | +315.22% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.88 | +788.32% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $10.08 | +68.65% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $329.39 | +6.26% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $30.32 | +213.32% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $12.27 | -30.73% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.45 | +82.63% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $9.03 | +88.26% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.70 | +214.81% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.20 | +5.99% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $169.20 | -13.71% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $60.71 | +74.60% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $187.90 | -16.44% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $329.00 | +11.85% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $264.60 | +139.98% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $67.75 | +72.69% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.49 | +107.04% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $345.55 | -13.76% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $134.50 | -29.37% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $523.75 | -5.49% | 1 | Oct 15, 2021 |
eHealth
Dec 4, 2024
Initiates: Neutral
Price Target: $5.5
Current: $6.68
Upside: -17.66%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.59
Upside: +11.42%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $13.11
Upside: +75.44%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $19.28
Upside: +29.67%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.17
Upside: +168.58%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $8.79
Upside: +36.52%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.41
Upside: +81.41%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $14.89
Upside: +74.61%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $29.55
Upside: -52.62%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $68.49
Upside: +40.17%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $16.70
Upside: +91.62%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $24.46
Upside: +329.27%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $101.28
Upside: -21.01%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $232.74
Upside: -0.75%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $92.63
Upside: +9.04%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.96
Upside: +239.20%
Jun 30, 2023
Maintains: Neutral
Price Target: $13 → $15
Current: $6.98
Upside: +114.90%
Jun 22, 2023
Maintains: Outperform
Price Target: $35 → $38
Current: $31.24
Upside: +21.64%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $137.77
Upside: -27.42%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $672.99
Upside: -33.13%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.89
Upside: +315.22%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.88
Upside: +788.32%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $10.08
Upside: +68.65%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $329.39
Upside: +6.26%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $30.32
Upside: +213.32%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $12.27
Upside: -30.73%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.45
Upside: +82.63%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $9.03
Upside: +88.26%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.70
Upside: +214.81%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.20
Upside: +5.99%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $169.20
Upside: -13.71%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $60.71
Upside: +74.60%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $187.90
Upside: -16.44%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $329.00
Upside: +11.85%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $264.60
Upside: +139.98%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $67.75
Upside: +72.69%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.49
Upside: +107.04%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $345.55
Upside: -13.76%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $134.50
Upside: -29.37%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $523.75
Upside: -5.49%